Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$57.32 USD

57.32
16,731,840

-0.08 (-0.14%)

Updated May 21, 2024 04:00 PM ET

After-Market: $57.30 -0.02 (-0.03%) 6:28 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 6% (233 out of 248)

Industry: Retail - Pharmacies and Drug Stores

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Indexes Start Lower As Trade Worries Persist

by Zacks Equity Research

U.S. stock index futures were lower on Wednesday as global trade war fears continue to dent investor confidence despite a robust second-quarter 2018 earnings season

    Buy These 6 Low Price-to-Book Stocks for Handsome Returns

    by Zacks Equity Research

    P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.

      CVS Health (CVS) Surpasses Q2 Earnings and Revenue Estimates

      by Zacks Equity Research

      CVS Health (CVS) delivered earnings and revenue surprises of 4.97% and 0.68%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

        Benjamin Rains headshot

        Buy Amazon (AMZN) Stock On Possible Gas Station & Travel Push?

        by Benjamin Rains

        Shares of Amazon (AMZN) popped Tuesday after D.A. Davidson analysts suggested that the next logical industries for the e-commerce giant to enter would be gas stations and travel. Amazon could likely jump into the gas station market without much fuss, similar to Costco (COST), and certainly has the online infrastructure and customer base to offer travel deals. But what should investors make of this?

          Should Value Investors Pick CVS Health (CVS) Stock Now?

          by Zacks Equity Research

          Let's see if CVS Health Corporation (CVS) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

            Rite Aid Stock Falls on FY19 View Cut Ahead of Merger Vote

            by Zacks Equity Research

            Rite Aid (RAD) lowers fiscal 2019 guidance as the generic drug purchasing efficiencies fall below expectations. Rite Aid shareholders are likely to vote for the Albertsons merger on Aug 9.

              Benjamin Rains headshot

              Why Amazon (AMZN) Stock Is A Strong Buy Right Now

              by Benjamin Rains

              Nearly everyone knows that Amazon (AMZN) stock has been one of the hottest on Wall Street for years. Yet some assume now is too late to get in on the fun, which simply isn't true. So let's take a look at why investors should buy Amazon stock right now following yet another quarter of stellar growth.

                Benjamin Rains headshot

                Why Apple Pay, AirPods, & Services Are More Vital Than Ever

                by Benjamin Rains

                Apple (AAPL) saw its stock price climb Wednesday as it inches ever closer to that elusive $1 trillion market cap. The firm's iPhone revenues surged once again during its fiscal Q3, but investors seem much more excited about Apple's growing Services unit, which features Apple Music, Apple Pay, along with other newer businesses.

                  Ryan McQueeney headshot

                  Apple Earnings Preview, Chipotle Woes, News from NAKD, CVS, SHOP | Free Lunch

                  by Ryan McQueeney

                  Ryan McQueeney discusses Chipotle's latest foodborne illness trouble, the new partnership between Naked Brands and CVS, and Shopify's earnings report. Later, he is joined by Zacks Strategist Brian Bolan to preview the upcoming earnings announcement of tech behemoth Apple.

                    Is CVS Health (CVS) a Great Value Stock Right Now?

                    by Zacks Equity Research

                    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

                      What's in the Cards for CVS Health (CVS) in Q2 Earnings?

                      by Zacks Equity Research

                      CVS Health (CVS) is optimistic about living up to its strong earnings surprise history year over year in Q2 as well, courtesy of gains from the Pharmacy Services segment.

                        5 Low Price-to-Book Stocks That Can Prove to be Valuable

                        by Zacks Equity Research

                        P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.

                          Chloe Shin headshot

                          One of Wall Street's Top Analysts Warns Against Trade War

                          by Chloe Shin

                          With the trade war looming upon us, Goldman Sachs chief U.S. equity strategist David Kostin warned investors about how it will affect U.S. Companies. According to Kostin, if trade tensions worsen, and a 10 percent tariff were imposed on all U.S. imports, Goldman would lower its 2019 S&P 500 EPS estimate by 15 percent.

                            Zacks.com featured highlights include: ConocoPhillips, Archer Daniels, CVS, Fortinet and Avnet

                            by Zacks Equity Research

                            Zacks.com featured highlights include: ConocoPhillips, Archer Daniels, CVS, Fortinet and Avnet

                              The Zacks Analyst Blog Highlights: CVS, RH, Groupon, Darden and Carrols

                              by Zacks Equity Research

                              The Zacks Analyst Blog Highlights: CVS, RH, Groupon, Darden and Carrols

                                5 Stocks Trading Near 52-Week High With More Room to Run

                                by Zacks Equity Research

                                Here are some stocks trading near their 52-week high levels with potential to scale higher.

                                  Tirthankar Chakraborty headshot

                                  Americans on a Spring Spending Spree: Top 5 Gainers

                                  by Tirthankar Chakraborty

                                  Big burst of spending in spring after a ho-hum winter is primarily backed by Trump's tax cuts, strong hiring and declining unemployment rate.

                                    Benjamin Rains headshot

                                    Buy Walgreens (WBA) Stock Because It's Cheap & Amazon Fears Are Overblown?

                                    by Benjamin Rains

                                    Shares of Walgreens Boots Alliance (WBA) are down 16.5% over the last year based mostly on Amazon (AMZN) fears. There is no doubt that online selling and delivery have altered the retail world, but does that mean Walgreens can no longer compete? Let's dive into some of WBA's fundamentals to see what to do with the stock.

                                      Sumit Singh headshot

                                      4 Retail Stocks to Buy as Q2 Earnings Season Knocks

                                      by Sumit Singh

                                      Search for safe havens has intensified ever since the trade hostility between the United States and China commenced. However, its high time that you bury the trade related fears and rejig your portfolio.

                                        Tracey Ryniec headshot

                                        Trade Wars and Recessions: What Should Investors Do?

                                        by Tracey Ryniec

                                        The best thing investors can do is have a plan. Find out where you should be investing in this uncertain market.

                                          Sweta Jaiswal headshot

                                          Amazon Forays Into Pharmacy Business: Red Alert for Others?

                                          by Sweta Jaiswal

                                          Amazon's entry into the high-potential pharmaceutical industry deals a blow to share prices of major players.

                                            Sapna Bagaria headshot

                                            Will Healthcare Buck Up on Amazon's Pillpack Takeover Deal?

                                            by Sapna Bagaria

                                            Amazon's (AMZN) use of technology, innovative strategies and skilled leadership should take it far in the healthcare space.

                                              Madeleine Johnson headshot

                                              NKE Beats Earnings, Spotify's Video Push, & AMZN's Big Pharma Purchase

                                              by Madeleine Johnson

                                              On today's episode of the Zacks Friday Finish Line, Editor Maddy Johnson is joined by Ben Rains, an Associate Stock Strategist here at Zacks, to take on this week's biggest stories, including Nike's latest quarterly earnings results, Spotify's media ambitions, and Amazon's latest assault on the healthcare industry.

                                                Afrasiab Mian headshot

                                                After a Historic Rise, Should You Still Buy Amazon (AMZN) Stock?

                                                by Afrasiab Mian

                                                With massive growth already baked into its stock price, many investors may feel that Amazon stock is too expensive and that they have missed their chance to cash in. Is this truly the case? Let's take a look.

                                                  Benjamin Rains headshot

                                                  Investors Shouldn't Panic About Amazon's PillPack Purchase

                                                  by Benjamin Rains

                                                  Shares of pharmacy giants CVS (CVS), Rite Aid (RAD), and Walgreens Boots Alliance (WBA) all plummeted on Thursday morning after Amazon (AZMN) announced its purchase of online pharmacy delivery startup PillPack. The move clearly has some investors worried that Amazon's push into the pharmaceutical industry will hurt the current powers. So let's take a look at more of the details to find out what's really going on.